Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Eisai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Eisai's 2012 sales performance.

Eisai Co., Ltd.

Another Alzheimer's bust as Merck stops verubecestat study

Another Alzheimer's bust as Merck stops verubecestat study

Another Alzheimer's bust as Merck stops verubecestat study. Late-stage BACE1 failure could be an ominous signal for Eli Lilly/AZ and Biogen/Eisai. ... Merck &Co has abandoned the phase III trial of its BACE1 inhibitor verubecestat in Alzheimer’s in

Boehringer abandons PDE-targeted Alzheimer’s drug

Boehringer abandons PDE-targeted Alzheimer’s drug An anti-amyloid drug developed by Boehringer and Eisai missed an interim analysis last December and now looks unlikely to show efficacy although final results are not expected until later this

BMS adds another Ono drug to its immuno-oncology portfolio

BMS adds another Ono drug to its immuno-oncology portfolio A few other groups have been developing EP4 receptor antagonists in cancer, including Eisai whose lead candidate E7046 is in phase I testing in Japan, and Eli Lilly which has completed

NICE set to reject wider use of Eisai’s breast cancer drug Halaven

NICE set to reject wider use of Eisai’s breast cancer drug Halaven NICE set to reject wider use of Eisai’ s breast cancer drug Halaven. ... Issues draft guidance recommending against second-line use. Eisai’s Halaven (eribulin) should not be funded by the NHS for earlier use in breast cancer patients, according to

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
...

Infographics